[Top Trade ideas] APRN, The Next Big Squeeze Play?

[Manage your email subscriptions.]( Good morning trader! Here are our top 3 trade ideas today. These setups look primed! Be the best prepared trader on the Street!  👉 Synaptogenix (SNPX) - This small cap biopharmaceutical company focused on not only stopping the harmful effects of Alzheimer’s but REVERSING these effects continues to trend Higher 👉 Jeff Williams is long APRN calls and thinks that this could be the next big squeeze play! 👉 Jason Bond is watching HUSA. This could Squeeze aggressively! Before we jump in… *This is an Issuer-Paid Advertisement, See Disclosure Below  Jeff Williams Scalps NHWK LIVE as it explodes over 20% in minutes Jeff Williams alerted NHWK[LIVE](to those in the [Wallstreet 360]( chat room yesterday. NHWK announced they would fund development of a monkeypox vaccine. This sent the stock gapping up over 20% in pre-market. Jeff was watching NHWK closely and bought the breakout of the intraday highs at $2.74. The stock pulled back some and consolidated, before making one final explosive move. Jeff was out at 2.93 in front of his $3 target, but there was more fun to be had. NWHK exploded through $3 to make a high of $3.42 in minutes. Don’t miss Jeff in the [360 Wall st chatroom](, as he alerts his best trade ideas in real time! [Click here to jump in the 360 Wallstreet chat room](  Sponsored By 👉 Synaptogenix (SNPX) operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. It focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. They are currently in Phase 2 trials and expect Phase 2 data later this year. SNPX is focusing on not only stopping the harmful effects of Alzheimer’s but REVERSING these effects. The trade setup here is known as a catalyst trade. Often, a stock can run up into the anticipated release of Biotech Data, as investors take early positions on the expectation of possibly good results. What happens on the release of the data is obviously unknown but increased demand into the event is possible. Technicals From the lows made in July, SNPX is up over 50% in just over a month. It ran from around $4.70 to a high of $8.75 made last week. Technically it is very strong, making higher lows and higher highs trending nicely. It closed yesterday at a price of $7.99 pulling back slightly from its highs and trading above the 200-day MA of $7.21. From a big picture, the next big resistance level is around $10 and the major support area is $6.60, so anywhere near $6.60, I would expect to see significant buyers step in as they have done in the past. However, given that SNPX is trading above $7.90, a prior level of resistance. If this becomes support, there is no guarantee that the stock will trade any lower, it could begin its march here to $10+ as the 13 and 30-day moving averages are pointing up and trending. All-time highs for SNPX is just over $14, and this is where this stock gets really exciting because above that there is only blue skies. From a fundamental standpoint, SNPX could be considered very cheap at these levels. Let me explain why: Fundamentals According to Finviz, currently SNPX has a market cap of $56.01 million. As of June 30, 2022 SNPX had $28.7 million in cash and cash equivalents. Given that they’ve received over $200million in funding and involvement from the NIH and Blanchette Rockefeller Neurosciences Institute, SNPX could be considered very undervalued at these levels. That type of funding cannot be easy to get. ATHA is a direct competitor to SNPX with a market capitalization of $138.66 million and book value of 7.45 according to Finviz. Given that SNPX’s book value is per share is 4.16 according to Finviz, on a relative valuation basis that leaves 50%+ upside in the short term. Successful Phase 2 data could be a game changer for this small-cap company. SAVA, another direct competitor, has a market cap of over 1 billion. SNPX at these levels has potential! *This is an Issuer-Paid Advertisement, See Disclosure Below  Jason Bond is watching HUSA. This could Squeeze aggressively! The volume and price is rising this week in this small cap oil stock as crude oil is bouncing aggressively off $90. If this trend continues Jason thinks that HUSA could squeeze from the $4 area to somewhere between $6-$8. This is a low float with a lot of shares short which could help fuel the move if it gets going. This stock has a history of explosive action, so there could be some fireworks here. Watch this one closely today!  Jeff Williams is long APRN calls and thinks that this could be the next big squeeze play! According to Finviz, APRN has a 43% short interest and Jeff thinks that if it breaks over $7 we could see a short squeeze to the $8’s or $9’s. APRN is already up about 8% in pre market after a strong 26% run yesterday. Given how weak the market was yesterday, APRN doesn’t care what is going on with the overall market. The volume was huge yesterday, and if there is a stubborn short that is stuck in this one, the sharks might smell blood here. If the big boys pile into this one, expect the possibility of an outsized move to the upside here. Another must watch for traders this morning. [Here is your direct link to the 360 chat room](  To your success! 62 Calef Hwy #233 Lee, New Hampshire 03861 United States Questions or concerns about our products? Email [Support@360.com]( © Copyright 2022, RagingBull - Refund Policy - Privacy Policy - Terms & Conditions  FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, neither Sherwood Ventures, LLC (“Sherwood”) nor Ragingbull.com, LLC (“Raging Bull”) can guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the companies mentioned in this advertisement, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this advertisement or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision. SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in any securities of the companies mentioned in this advertisement should do so with caution. Investing or transacting in any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments. NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither Sherwood nor Raging Bull, or any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Raging Bull does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the companies profiled in the Advertisements at. TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied. ISSUER-PAID ADVERTISEMENT. Synaptogenix, Inc. (“SNPX” or the “Company”) has paid or will pay Sherwood $30,000 USD per month for three months (the “Initial Term”) in cash, shares of restricted common stock with a value of $150,000, and warrants valued at issuance of $75,000 for marketing services including communicating to the public about the company through Sherwood’s affiliate Raging Bull, among others. This advertisement is part of those issuer-paid marketing services. The contract with SNPX automatically renews for successive one-month periods following the Initial Term (the “Renewal Term”) unless it is terminated by written notice of either party prior to the end of the previous term. During the Renewal Term, SNPX has agreed to pay Sherwood a monthly fee of $30,000 in cash, shares of restricted stock with a value of $50,000 and warrants valued at $25,000. As a result of this advertisement and other marketing efforts, Sherwood and/or Raging Bull may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Sherwood and Raging Bull, and any of their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) hold the securities of SNPX and, as permitted by law, may sell those shares during the course of this marketing arrangement or afterwards. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of SNPX, increased trading volume, and possibly an increased share price of the SNPX’s securities, which may or may not be temporary and decrease once the marketing arrangement has ended. DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of [RagingBull.com](, LLC are paid in whole or in part by commission based on their sales of Services to subscribers. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.